Undervalued Large-Cap Healthcare Stocks on NYS September 2023

September 22, 2023

Healthcare Sector

The healthcare sector includes companies in biotechnology, pharmaceuticals, hospitals, home and long-term care. It also includes related medical equipment manufacturers and suppliers.

New York Stock Exchange

The New York Stock Exchange, located in New York City, is the largest securities exchange in the world by market capitalization of its listed companies.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Healthcare stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
BAX Baxter Intl 38.47 47.08 22.38 3572768 19466 3.02 0.0
QGEN Qiagen 40.37 48.63 20.45 1331832 9306 0.00 27.5
CI Cigna Group 287.33 341.86 18.98 1064202 84622 1.67 13.2
MDT Medtronic 81.48 96.81 18.81 5281668 108678 3.35 30.1
BIO Bio-Rad Laboratories 364.42 432.65 18.72 166011 10698 0.00 0.0
PRGO Perrigo 33.37 39.33 17.88 1561635 4558 3.23 0.0
TAK Takeda Pharmaceutical 16.29 19.19 17.80 1594226 50989 2.02 25.1
NVO Novo Nordisk 94.73 110.14 16.27 4111419 426531 1.09 44.4
DGX Quest Diagnostics 125.01 145.23 16.17 747240 14251 2.19 18.1
LH Laboratory Corp 205.20 236.35 15.18 847892 18284 1.40 19.2
All data provided as at market close September 19, 2023.

Company Details

Baxter Intl

BAX:NYS

Close Price

38.47

Our Valuation

47.08

% Difference

22.38

Market Cap ($M)

19466

P/E Ratio

0.0

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.

Access the stockcalc valuation


Qiagen

QGEN:NYS

Close Price

40.37

Our Valuation

48.63

% Difference

20.45

Market Cap ($M)

9306

P/E Ratio

27.5

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (45% of 2021 sales), followed by EMEA (36%), and Asia-Pacific (19%).

Access the stockcalc valuation


Cigna Group

CI:NYS

Close Price

287.33

Our Valuation

341.86

% Difference

18.98

Market Cap ($M)

84622

P/E Ratio

13.2

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense and it recently won a deal with top-tier insurer Centene.

Access the stockcalc valuation


Medtronic

MDT:NYS

Close Price

81.48

Our Valuation

96.81

% Difference

18.81

Market Cap ($M)

108678

P/E Ratio

30.1

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Bio-Rad Laboratories

BIO:NYS

Close Price

364.42

Our Valuation

432.65

% Difference

18.72

Market Cap ($M)

10698

P/E Ratio

0.0

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing.

Access the stockcalc valuation


Perrigo

PRGO:NYS

Close Price

33.37

Our Valuation

39.33

% Difference

17.88

Market Cap ($M)

4558

P/E Ratio

0.0

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS.

Access the stockcalc valuation


Takeda Pharmaceutical

TAK:NYS

Close Price

16.29

Our Valuation

19.19

% Difference

17.80

Market Cap ($M)

50989

P/E Ratio

25.1

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Access the stockcalc valuation


Novo Nordisk

NVO:NYS

Close Price

94.73

Our Valuation

110.14

% Difference

16.27

Market Cap ($M)

426531

P/E Ratio

44.4

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments.

Access the stockcalc valuation


Quest Diagnostics

DGX:NYS

Close Price

125.01

Our Valuation

145.23

% Difference

16.17

Market Cap ($M)

14251

P/E Ratio

18.1

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals.

Access the stockcalc valuation


Laboratory Corp

LH:NYS

Close Price

205.20

Our Valuation

236.35

% Difference

15.18

Market Cap ($M)

18284

P/E Ratio

19.2

Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Baxter Intl and Qiagen are the most undervalued Large-Cap Healthcare stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-september-2023
Baxter Intl $BAX and Qiagen $QGEN are the most undervalued Healthcare stocks on the #NYS. See the full list: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-september-2023
Baxter Intl and Qiagen are the most undervalued Large-Cap Healthcare stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-september-2023

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.